Small colony variants (SCVs) of Staphylococcus aureus - A bacterial survival strategy

Infection, Genetics and Evolution

Volumn 21, Issue , 2014, Pages 515-522

  Kahl, Barbara C ^a  

^a UNIVERSITY HOSPITAL MÜNSTER   (Germany)

Author keywords

Intracellular; Persistence; Small colony variants; Staphylococcus aureus; Stress response; Survival strategy

Indexed keywords

ANTIINFECTIVE AGENT;

ANTIBIOTIC RESISTANCE; GENE EXPRESSION REGULATION; GENETIC VARIABILITY; GENETICS; HUMAN; MICROBIOLOGY; PATHOGENICITY; PHENOTYPE; PHYSIOLOGY; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION; VIRULENCE;

ANTI-BACTERIAL AGENTS; DRUG RESISTANCE, BACTERIAL; GENE EXPRESSION REGULATION, BACTERIAL; GENETIC VARIATION; HUMANS; PHENOTYPE; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; VIRULENCE;

EID: 84893720330     PISSN: 15671348     EISSN: 15677257     Source Type: Journal    
DOI: 10.1016/j.meegid.2013.05.016     Document Type: Article

References (100)

1. Alkasir R., Liu X., Zahra M., Ferreri M., Su J., Han B. Characteristics of Staphylococcus aureus small colony variant and its parent strain isolated from chronic mastitis at a dairy farm in Beijing, China. Microb. Drug Resist. 2013, 19:138-145.
2. Atalla H., Gyles C., Jacob C.L., Moisan H., Malouin F., Mallard B. Characterization of a Staphylococcus aureus small colony variant (SCV) associated with persistent bovine mastitis. Foodborne Pathog. Dis. 2008, 5:785-799.
3. Atalla H., Gyles C., Mallard B. Staphylococcus aureus small colony variants (SCVs) and their role in disease. Anim. Health Res. Rev. 2011, 12:33-45.
4. Atalla H., Wilkie B., Gyles C., Leslie K., Mutharia L., Mallard B. Antibody and cell-mediated immune responses to Staphylococcus aureus small colony variants and their parental strains associated with bovine mastitis. Dev. Comp. Immunol. 2010, 34:1283-1290.
5. Atkins B., Gottlieb T. Fusidic acid in bone and joint infections. Int. J. Antimicrob. Agents 1999, 12(Suppl. 2):S79-S93.
6. Balwit J.M., van Langevelde P., Vann J.M., Proctor R.A. Gentamicin-resistant menadione and hemin auxotrophic Staphylococcus aureus persist within cultured endothelial cells. J. Infect. Dis. 1994, 170:1033-1037.
7. Baumert N., von Eiff C., Schaaf F., Peters G., Proctor R.A., Sahl H.G. Physiology and antibiotic susceptibility of Staphylococcus aureus small colony variants. Microb. Drug Resist. 2002, 8:253-260.
8. Bayston R., Ashraf W., Smith T. Triclosan resistance in methicillin-resistant Staphylococcus aureus expressed as small colony variants: a novel mode of evasion of susceptibility to antiseptics. J. Antimicrob. Chemother. 2007, 59:848-853.
9. Beaume M., Hernandez D., Docquier M., Delucinge-Vivier C., Descombes P., Francois P. Orientation and expression of methicillin-resistant Staphylococcus aureus small RNAs by direct multiplexed measurements using the nCounter of nanoString technology. J. Microbiol. Methods 2011, 84:327-334.
10. Besier S., Ludwig A., Ohlsen K., Brade V., Wichelhaus T.A. Molecular analysis of the thymidine-auxotrophic small colony variant phenotype of Staphylococcus aureus. Int. J. Med. Microbiol. 2007, 297:217-225.
11. Besier S., Smaczny C., von M.C., Krahl A., Ackermann H., Brade V., Wichelhaus T.A. Prevalence and clinical significance of Staphylococcus aureus small-colony variants in cystic fibrosis lung disease. J. Clin. Microbiol. 2007, 45:168-172.
12. Besier S., Zander J., Kahl B.C., Kraiczy P., Brade V., Wichelhaus T.A. The thymidine-dependent small-colony-variant phenotype is associated with hypermutability and antibiotic resistance in clinical Staphylococcus aureus isolates. Antimicrob. Agents Chemother. 2008, 52:2183-2189.
13. Besier S., Zander J., Siegel E., Saum S.H., Hunfeld K.P., Ehrhart A., Brade V., Wichelhaus T.A. Thymidine-dependent Staphylococcus aureus small-colony variants: human pathogens that are relevant not only in cases of cystic fibrosis lung disease. J. Clin. Microbiol. 2008, 46:3829-3832.
14. Biswas L., Biswas R., Schlag M., Bertram R., Gotz F. Small-colony variant selection as a survival strategy for Staphylococcus aureus in the presence of Pseudomonas aeruginosa. Appl. Environ. Microbiol. 2009, 75:6910-6912.
15. Boles B.R., Thoendel M., Singh P.K. Self-generated diversity produces "insurance effects" in biofilm communities. Proc. Natl. Acad. Sci. USA 2004, 101:16630-16635.
16. Chatterjee I., Kriegeskorte A., Fischer A., Deiwick S., Theimann N., Proctor R.A., Peters G., Herrmann M., Kahl B.C. In vivo mutations of thymidylate synthase (thyA) are responsible for thymidine-dependency in clinical small colony variants (TD-SCVs) of Staphylococcus aureus. J. Bacteriol. 2008, 190:834-842.
17. Cleeve V.J., Perry J.D., Cresswell G., Orr K.E. Thymidine-dependent meticillin-resistant Staphylococcus aureus: a potentially unrecognized reservoir of MRSA in hospital patients?. J. Hosp. Infect. 2006, 63:228-229.
18. CLSI Performance Standards for Antimicrobial Disk Susceptibility Tests. Approved Standards 2012, Clinical and Laboratory Standards Institute, Wayne, PA.
19. Demazeau G., Rivalain N. The development of high hydrostatic pressure processes as an alternative to other pathogen reduction methods. J. Appl. Microbiol. 2011, 110:1359-1369.
20. Doring G., Flume P., Heijerman H., Elborn J.S. Treatment of lung infection in patients with cystic fibrosis: current and future strategies. J. Cyst. Fibros. 2012, 11:461-479.
21. Duval B.D., Mathew A., Satola S.W., Shafer W.M. Altered growth, pigmentation, and antimicrobial susceptibility properties of Staphylococcus aureus due to loss of the major cold shock gene cspB. Antimicrob. Agents Chemother. 2010, 54:2283-2290.
22. Edwards A.M. Phenotype switching is a natural consequence of Staphylococcus aureus replication. J. Bacteriol. 2012, 194:5404-5412.
23. von Eiff C., Heilmann C., Proctor R.A., Wolz C., Peters G., Gotz F. A site-directed Staphylococcus aureus hemB mutant is a small-colony variant which persists intracellularly. J. Bacteriol. 1997, 179:4706-4712.
24. Ford H.R., Jones P., Gaines B., Reblock K., Simpkins D.L. Intraoperative handling and wound healing: controlled clinical trial comparing coated VICRYL plus antibacterial suture (coated polyglactin 910 suture with triclosan) with coated VICRYL suture (coated polyglactin 910 suture). Surg. Infect. (Larchmt.) 2005, 6:313-321.
25. Gao W., Chua K., Davies J.K., Newton H.J., Seemann T., Harrison P.F., Holmes N.E., Rhee H.W., Hong J.I., Hartland E.L., Stinear T.P., Howden B.P. Two novel point mutations in clinical Staphylococcus aureus reduce linezolid susceptibility and switch on the stringent response to promote persistent infection. PLoS Pathog. 2010, 6:e1000944.
26. Garcia L.G., Lemaire S., Kahl B.C., Becker K., Proctor R.A., Denis O., Tulkens P.M., Van B.F. Pharmacodynamic evaluation of the activity of antibiotics against hemin- and menadione-dependent small-colony variants of Staphylococcus aureus in models of extracellular (broth) and intracellular (THP-1 monocytes) infections. Antimicrob. Agents Chemother. 2012, 56:3700-3711.
27. Garcia L.G., Lemaire S., Kahl B.C., Becker K., Proctor R.A., Denis O., Tulkens P.M., Van Bambeke F. Antibiotic activity against small-colony variants of Staphylococcus aureus: review of in vitro, animal and clinical data. J. Antimicrob. Chemother 2013, Ahead of print.
28. Gilligan P.H., Gage P.A., Welch D.F., Muszynski M.J., Wait K.R. Prevalence of thymidine-dependent Staphylococcus aureus in patients with cystic fibrosis. J. Clin. Microbiol. 1987, 25:1258-1261.
29. Gomez-Gonzalez C., Acosta J., Villa J., Barrado L., Sanz F., Orellana M.A., Otero J.R., Chaves F. Clinical and molecular characteristics of infections with CO2-dependent small-colony variants of Staphylococcus aureus. J. Clin. Microbiol. 2010, 48:2878-2884.
30. Haussler S., Lehmann C., Breselge C., Rohde M., Classen M., Tummler B., Vandamme P., Steinmetz I. Fatal outcome of lung transplantation in cystic fibrosis patients due to small-colony variants of the Burkholderia cepacia complex. Eur. J. Clin. Microbiol. Infect. Dis. 2003, 22:249-253.
31. Haussler S., Rohde M., Steinmetz I. Highly resistant Burkholderia pseudomallei small colony variants isolated in vitro and in experimental melioidosis. Med. Microbiol. Immunol. 1999, 188:91-97.
32. Haussler S., Tummler B., Weissbrodt H., Rohde M., Steinmetz I. Small-colony variants of Pseudomonas aeruginosa in cystic fibrosis. Clin. Infect. Dis. 1999, 29:621-625.
33. Hoffman L.R., Deziel E., D'Argenio D.A., Lepine F., Emerson J., McNamara S., Gibson R.L., Ramsey B.W., Miller S.I. Selection for Staphylococcus aureus small-colony variants due to growth in the presence of Pseudomonas aeruginosa. Proc. Natl. Acad. Sci. USA 2006, 103:19890-19895.
34. Idelevich E.A., Kriegeskorte A., Stubbings W., Kahl B.C., Peters G., Becker K. Comparative in vitro activity of finafloxacin against staphylococci displaying normal and small colony variant phenotypes. J. Antimicrob. Chemother. 2011, 66:2809-2813.
35. Kahl B.C., Belling G., Becker P., Chatterjee I., Wardecki K., Hilgert K., Cheung A.L., Peters G., Herrmann M. Thymidine-dependent Staphylococcus aureus small colony variants (SCV) are associated with extensive changes in regulator and virulence gene expression profiles. Infect. Immun. 2005, 73:4119-4126.
36. Kahl B., Herrmann M., Everding A.S., Koch H.G., Becker K., Harms E., Proctor R.A., Peters G. Persistent infection with small colony variant strains of Staphylococcus aureus in patients with cystic fibrosis. J. Infect. Dis. 1998, 177:1023-1029.
37. Kahl B.C., Belling G., Reichelt R., Herrmann M., Proctor R.A., Peters G. Thymidine-dependent small-colony variants of Staphylococcus aureus exhibit gross morphological and ultrastructural changes consistent with impaired cell separation. J. Clin. Microbiol. 2003, 41:410-413.
38. Kaplan M.L., Dye W. Growth requirements of some small-colony-forming variants of Staphylococcus aureus. J. Clin. Microbiol. 1976, 4:343-348.
39. Karatzas K.A., Zervos A., Tassou C.C., Mallidis C.G., Humphrey T.J. Piezotolerant small-colony variants with increased thermotolerance, antibiotic susceptibility, and low invasiveness in a clonal Staphylococcus aureus population. Appl. Environ. Microbiol. 2007, 73:1873-1881.
40. Kim R., Freeman J., Waldvogel-Thurlow S., Roberts S., Douglas R. The characteristics of intramucosal bacteria in chronic rhinosinusitis: a prospective cross-sectional analysis. Int. Forum Allergy Rhinol. 2013, 3:349-354.
41. Kipp F., Becker K., Peters G., von E.C. Evaluation of different methods to detect methicillin resistance in small-colony variants of Staphylococcus aureus. J. Clin. Microbiol 2004, 42:1277-1279.
42. Kipp F., Kahl B.C., Becker K., Baron E.J., Proctor R.A., Peters G., von Eiff C. Evaluation of two chromogenic agar media for recovery and identification of Staphylococcus aureus small-colony variants. J. Clin. Microbiol. 2005, 43:1956-1959.
43. Kipp F., Ziebuhr W., Becker K., Krimmer V., Hobeta N., Peters G., von Eiff C. Detection of Staphylococcus aureus by 16S rRNA directed in situ hybridisation in a patient with a brain abscess caused by small colony variants. J. Neurol. Neurosurg. Psychiatry 2003, 74:1000-1002.
44. Knudsen B.E., Chew B.H., Denstedt J.D. Drug-eluting biomaterials in urology: the time is ripe. BJU Int. 2005, 95:726-727.
45. Kohler C., von Eiff C., Peters G., Proctor R.A., Hecker M., Engelmann S. Physiological characterization of a heme-deficient mutant of Staphylococcus aureus by a proteomic approach. J. Bact. 2003, 185:6928-6937.
46. Koo S.P., Bayer A.S., Sahl H.G., Proctor R.A., Yeaman M.R. Staphylocidal action of thrombin-induced platelet microbicidal protein is not solely dependent on transmembrane potential. Infect. Immun. 1996, 64:1070-1074.
47. Kriegeskorte A., König S., Sander G., Pirkl A., Mahabir E., Proctor R.A., von E.C., Peters G., Becker K. Small colony variants of Staphylococcus aureus reveal distinct protein profiles. Proteomics 2011, 11:2476-2490.
48. Lannergard J., Cao S., Norstrom T., Delgado A., Gustafson J.E., Hughes D. Genetic complexity of fusidic acid-resistant small colony variants (SCV) in Staphylococcus aureus. PLoS One 2011, 6:e28366.
49. Lannergard J., Eiff von C., Sander G., Cordes T., Seggewiss J., Peters G., Proctor R.A., Becker K., Hughes D. Identification of the genetic basis for clinical menadione-auxotrophic small-colony variant isolates of Staphylococcus aureus. Antimicrob. Agents Chemother. 2008, 52:4017-4022.
50. Lannergard J., Norstrom T., Hughes D. Genetic determinants of resistance to fusidic acid among clinical bacteremia isolates of Staphylococcus aureus. Antimicrob. Agents Chemother. 2009, 53:2059-2065.
51. Lasa I., Toledo-Arana A., Dobin A., Villanueva M., Villanueva M., de los Mozos I.R., Vergara-Irigaray M., Segura V., Fagegaltier D., Penades J.R., Valle J., Solano C., Gingeras T.R. Genome-wide antisense transcription drives mRNA processing in bacteria. Proc. Natl. Acad. Sci. USA 2011, 108:20172-20177.
52. Levy S.B. Antibacterial household products: cause for concern. Emerg. Infect. Dis. 2001, 7:512-515.
53. Maduka-Ezeh A., Seville M.T., Kusne S., Vikram H.R., BLAIR J.E., Greenwood-Quaintance K., Arabia F., Patel R. Thymidine auxotrophic Staphylococcus aureus small-colony variant endocarditis and left ventricular assist device infection. J. Clin. Microbiol. 2012, 50:1102-1105.
54. Massey R.C., Buckling A., Peacock S.J. Phenotypic switching of antibiotic resistance circumvents permanent costs in Staphylococcus aureus. Curr. Biol. 2001, 11:1810-1814.
55. McCarthy L.R., Chmel H., Bell G., Armstrong D. Thymidine-dependent strain of Salmonella oslo selected by trimethoprim-sulfamethoxazole therapy. Am. J. Clin. Pathol. 1977, 68:307-311.
56. Melter O., Radojevic B. Small colony variants of Staphylococcus aureus - review. Folia Microbiol. (Praha) 2010, 55:548-558.
57. Miller M.H., Wexler M.A., Steigbigel N.H. Single and combination antibiotic therapy of Staphylococcus aureus experimental endocarditis: emergence of gentamicin-resistant mutants. Antimicrob. Agents Chemother. 1978, 14:336-343.
58. Mitchell G., Brouillette E., Seguin D.L., Asselin A.E., Jacob C.L., Malouin F. A role for sigma factor B in the emergence of Staphylococcus aureus small-colony variants and elevated biofilm production resulting from an exposure to aminoglycosides. Microb. Pathog. 2010, 48:18-27.
59. Mitchell G., Gattuso M., Grondin G., Marsault E., Bouarab K., Malouin F. Tomatidine inhibits replication of Staphylococcus aureus small-colony variants in cystic fibrosis airway epithelial cells. Antimicrob. Agents Chemother. 2011, 55:1937-1945.
60. Mitchell G., Lamontagne C.A., Brouillette E., Grondin G., Talbot B.G., Grandbois M., Malouin F. Staphylococcus aureus SigB activity promotes a strong fibronectin-bacterium interaction which may sustain host tissue colonization by small-colony variants isolated from cystic fibrosis patients. Mol. Microbiol. 2008, 70:1540-1555.
61. Mitchell G., Seguin D.L., Asselin A.E., Deziel E., Cantin A.M., Frost E.H., Michaud S., Malouin F. Staphylococcus aureus sigma B-dependent emergence of small-colony variants and biofilm production following exposure to Pseudomonas aeruginosa 4-hydroxy-2-heptylquinoline-N-oxide. BMC Microbiol. 2010, 10:33.
62. Mitsuyama J., Yamada H., Maehana J., Fukuda Y., Kurose S., Minami S., Todo Y., Watanabe Y., Narita H. Characteristics of quinolone-induced small colony variants in Staphylococcus aureus. J. Antimicrob. Chemother. 1997, 39:697-705.
63. Moisan H., Brouillette E., Jacob C.L., Langlois-Begin P., Michaud S., Malouin F. Transcription of virulence factors in Staphylococcus aureus small-colony variants isolated from cystic fibrosis patients is influenced by SigB. J. Bacteriol. 2006, 188:64-76.
64. Nguyen H.A., Denis O., Vergison A., Theunis A., Tulkens P.M., Struelens M.J., Van B.F. Intracellular activity of antibiotics in a model of human THP-1 macrophages infected by a Staphylococcus aureus small-colony variant strain isolated from a cystic fibrosis patient: pharmacodynamic evaluation and comparison with isogenic normal-phenotype and revertant strains. Antimicrob. Agents Chemother. 2009, 53:1434-1442.
65. Nguyen H.A., Denis O., Vergison A., Tulkens P.M., Struelens M.J., Van B.F. Intracellular activity of antibiotics in a model of human THP-1 macrophages infected by a Staphylococcus aureus small-colony variant strain isolated from a cystic fibrosis patient: study of antibiotic combinations. Antimicrob. Agents Chemother. 2009, 53:1443-1449.
66. Norstrom T., Lannergard J., Hughes D. Genetic and phenotypic identification of fusidic acid-resistant mutants with the small-colony-variant phenotype in Staphylococcus aureus. Antimicrob. Agents Chemother. 2007, 51:4438-4446.
67. Oliver A., Canton R., Campo P., Baquero F., Blazquez J. High frequency of hypermutable Pseudomonas aeruginosa in cystic fibrosis lung infection. Science 2000, 288:1251-1254.
68. Onyango L.A., Dunstan R.H., Gottfries J., von E.C., Roberts T.K. Effect of low temperature on growth and ultra-structure of Staphylococcus spp. PLoS One 2012, 7:e29031.
69. Pan X.S., Hamlyn P.J., Talens-Visconti R., Alovero F.L., Manzo R.H., Fisher L.M. Small-colony mutants of Staphylococcus aureus allow selection of gyrase-mediated resistance to dual-target fluoroquinolones. Antimicrob. Agents Chemother. 2002, 46:2498-2506.
70. Pelletier L.L., Richardson M., Feist M. Virulent gentamicin-induced small colony variants of Staphylococcus aureus. J. Lab. Clin. Med. 1979, 94:324-334.
71. Proctor R.A., Eiff von C., Kahl B.C., Becker K., Mc Namara P.J., Herrmann M., Peters G. Small colony variants: a pathogenic form of bacteria that facilitates persistent and recurrent infections. Nat. Rev. Microbiol. 2006, 4:295-305.
72. Proctor R.A., Balwit J.M., Vesga O. Variant subpopulations of Staphylococcus aureus as cause of persistent and recurrent infections. Infect. Agents Dis. 1994, 3:302-312.
73. Proctor R.A., van Langevelde P., Kristjansson M., Maslow J.N., Arbeit R.D. Persistent and relapsing infections associated with small-colony variants of Staphylococcus aureus. Clin. Infect. Dis. 1995, 20:95-102.
74. Prunier A.L., Malbruny B., Laurans M., Brouard J., Duhamel J.F., Leclercq R. High rate of macrolide resistance in Staphylococcus aureus strains from patients with cystic fibrosis reveals high proportions of hypermutable strains. J. Infect. Dis. 2003, 187:1709-1716.
75. Ramli N.S., Eng G.C., Nathan S., Vadivelu J. The effect of environmental conditions on biofilm formation of Burkholderia pseudomallei clinical isolates. PLoS One 2012, 7:e44104.
76. Roggenkamp A., Sing A., Hornef M., Brunner U., Autenrieth I.B., Heesemann J. Chronic prosthetic hip infection caused by a small-colony variant of Escherichia coli. J. Clin. Microbiol. 1998, 36:2530-2534.
77. Rolauffs B., Bernhardt T.M., von E.C., Hart M.L., Bettin D. Osteopetrosis, femoral fracture, and chronic osteomyelitis caused by Staphylococcus aureus small colony variants (SCV) treated by girdlestone resection - 6-year follow-up. Arch. Orthop. Trauma Surg. 2002, 122:547-550.
78. Sadowska B., Cochard T., Poutrel B., Pytlos M., Bonar A., Gatkowska J., Rudnicka W., Polak J., Bielecki S., Siwinska-Gol b.H., Rozalska B. Characterization of Staphylococcus aureus strains isolated from cystic fibrosis patients by conventional and molecular typing. Acta Microbiol. Pol. 2001, 50:251-261.
79. Samuelsen O., Haukland H.H., Kahl B.C., von E.C., Proctor R.A., Ulvatne H., Sandvik K., Vorland L.H. Staphylococcus aureus small colony variants are resistant to the antimicrobial peptide lactoferricin B. J. Antimicrob. Chemother. 2005, 56:1126-1129.
80. Schaaff F., Bierbaum G., Baumert N., Bartmann P., Sahl H.G. Mutations are involved in emergence of aminoglycoside-induced small colony variants of Staphylococcus aureus. Int. J. Med. Microbiol. 2003, 293:427-435.
81. Seaman P.F., Ochs D., Day M.J. Small-colony variants: a novel mechanism for triclosan resistance in methicillin-resistant Staphylococcus aureus. J. Antimicrob. Chemother. 2007, 59:43-50.
82. Seggewiss J., Becker K., Kotte O., Eisenacher M., Yazdi M.R., Fischer A., McNamara P., Al L.N., Proctor R., Peters G., Heinemann M., Eiff von C. Reporter metabolite analysis of transcriptional profiles of a Staphylococcus aureus strain with normal phenotype and its isogenic hemB mutant displaying the small-colony-variant phenotype. J. Bacteriol. 2006, 188:7765-7777.
83. Seifert H., von Eiff C., Fatkenheuer G. Fatal case due to methicillin-resistant Staphylococcus aureus small colony variants in an AIDS patient. Emerg. Infect. Dis. 1999, 5:450-453.
84. Seifert H., Wisplinghoff H., Schnabel P., von Eiff C. Small colony variants of Staphylococcus aureus and pacemaker-related infection. Emerg. Infect. Dis. 2003, 9:1316-1318.
85. Sendi P., Proctor R.A. Staphylococcus aureus as an intracellular pathogen: the role of small colony variants. Trends Microbiol. 2009, 17:54-58.
86. Singh R., Ray P., Das A., Sharma M. Role of persisters and small-colony variants in antibiotic resistance of planktonic and biofilm-associated Staphylococcus aureus: an in vitro study. J. Med. Microbiol. 2009, 58:1067-1073.
87. Singh R., Ray P., Das A., Sharma M. Enhanced production of exopolysaccharide matrix and biofilm by a menadione-auxotrophic Staphylococcus aureus small-colony variant. J. Med. Microbiol. 2010, 59:521-527.
88. Spanu T., Romano L., D'Inzeo T., Masucci L., Albanese A., Papacci F., Marchese E., Sanguinetti M., Fadda G. Recurrent ventriculoperitoneal shunt infection caused by small-colony variants of Staphylococcus aureus. Clin. Infect. Dis. 2005, 41:e48-e52.
89. Stryer L. Biosynthesis of nucleotides. Biochemistry 1995, 739-762. W.H. Freemann and Company.
90. Swingle E.L. Studies on small colony variants of Staphylococcus aureus. J. Bacteriol. 1935, 29:467-489.
91. Takeuchi F., Watanabe S., Baba T., Yuzawa H., Ito T., Morimoto Y., Kuroda M., Cui L., Takahashi M., Ankai A., Baba S., Fukui S., Lee J.C., Hiramatsu K. Whole-genome sequencing of Staphylococcus haemolyticus uncovers the extreme plasticity of its genome and the evolution of human-colonizing staphylococcal species. J. Bacteriol. 2005, 187:7292-7308.
92. Tuchscherr L., Heitmann V., Hussain M., Viemann D., Roth J., von E.C., Peters G., Becker K., Loffler B. Staphylococcus aureus small-colony variants are adapted phenotypes for intracellular persistence. J. Infect. Dis. 2010, 202:1031-1040.
93. Tuchscherr L., Medina E., Hussain M., Volker W., Heitmann V., Niemann S., Holzinger D., Roth J., Proctor R.A., Becker K., Peters G., Loffler B. Staphylococcus aureus phenotype switching: an effective bacterial strategy to escape host immune response and establish a chronic infection. EMBO Mol. Med. 2011, 3:129-141.
94. Vaudaux P., Huggler E., Rhys-Williams W., Love W.G., Lew D.P. Extracellular and intracellular bactericidal activities of XF-70 against small-colony variant hemB mutants of meticillin-susceptible and meticillin-resistant Staphylococcus aureus. Int. J. Antimicrob. Agents 2011, 37:576-579.
95. Vergison A., Denis O., Deplano A., Casimir G., Claeys G., DeBaets F., DeBoeck K., Douat N., Franckx H., Gigi J., Ieven M., Knoop C., Lebeque P., Lebrun F., Malfroot A., Paucquay F., Pierard D., Van E.J., Struelens M.J. National survey of molecular epidemiology of Staphylococcus aureus colonization in Belgian cystic fibrosis patients. J. Antimicrob. Chemother. 2007, 59:893-899.
96. Vesga O., Groeschel M.C., Otten M.F., Brar D.W., Vann J.M., Proctor R.A. Staphylococcus aureus small colony variants are induced by the endothelial cell intracellular milieu. J. Infect. Dis. 1996, 173:739-742.
97. von Eiff C., McNamara P., Becker K., Bates D., Lei X.H., Ziman M., Bochner B.R., Peters G., Proctor R.A. Phenotype microarray profiling of Staphylococcus aureus menD and hemB mutants with the small-colony-variant phenotype. J. Bacteriol. 2006, 188:687-693.
98. Wellinghausen N., Chatterjee I., Berger A., Niederfuehr A., Proctor R.A., Kahl B.C. Characterization of clinical Enterococcus faecalis small-colony variants. J. Clin. Microbiol. 2009, 47:2802-2811.
99. Werth N., Beerlage C., Rosenberger C., Yazdi A.S., Edelmann M., Amr A., Bernhardt W., von E.C., Becker K., Schafer A., Peschel A., Kempf V.A. Activation of hypoxia inducible factor 1 is a general phenomenon in infections with human pathogens. PLoS One 2010, 5:e11576.
100. Yagci S., Hascelik G., Dogru D., Ozcelik U., Sener B. Prevalence and genetic diversity of Staphylococcus aureus small-colony variants in cystic fibrosis patients. Clin. Microbiol. Infect. 2013, 19:77-84.